Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUniversidade Estadual de Campinaspt_BR
dc.typeArtigo de periódicopt_BR
dc.titleOvarian cysts in users of Implanon (R) and Jadelle (R) subdermal contraceptive implantspt_BR
dc.contributor.authorHidalgo, MMpt_BR
dc.contributor.authorLisondo, Cpt_BR
dc.contributor.authorJuliato, CTpt_BR
dc.contributor.authorEspejo-Arce, Xpt_BR
dc.contributor.authorMonteiro, Ipt_BR
dc.contributor.authorBahamondes, Lpt_BR
unicamp.authorUniv Estadual Campinas, Human Reprod Unit, Dept Obstet & Gynecol, Sch Med, BR-13084971 Campinas, SP, Brazilpt_BR
dc.subjectcontraceptive implantspt_BR
dc.subjectImplanon (R)pt_BR
dc.subjectJadelle (R)pt_BR
dc.subjectovarian folliclespt_BR
dc.subject.wosTerm Norplant Usept_BR
dc.subject.wosIntrauterine Systempt_BR
dc.subject.wosSperm Penetrationpt_BR
dc.subject.wosLuteal Phasept_BR
dc.description.abstractObjective: To evaluate the prevalence of ovarian cysts in users of two contraceptive implants compared to users of intrauterine contraceptive (IUC). Materials and Methods: A total of 344 women were enrolled at 3 months of use of the elonogestrel-releasing implant (Implanonl (R)), the levonorgestrel-releasing implant (Jadelle (R)) or the TCu380A IUC. Bimanual pelvic examination and vaginal ultrasound were performed during routine 3-, 6- and 12-month visits of asymptomatic women. Women with ovarian cysts (or enlarged ovarian follicles >= 25 mm) were assessed weekly until disappearance or reduction of the image [including estradiol (E-2) and progesterone (P) measurement], and women with no ovarian enlargement underwent the same evaluation for the same period of time. Results: Ovarian cysts were detected in 5.2%, 13.0% and 1.9% of users of Implanon (R), Jadelle (R) and IUC, respectively, at 3 months. At 6 months of use, prevalence was 7.2%, 8.0% and 2.1%, whereas 12-month rates were 26.7%, 14.6% and 1.2% in the three groups, respectively. E2 levels were significantly higher among users with ovarian cysts than controls. The time until disappearance of the ovarian cyst was similar in all three groups. There were more cases of menorrhagia in users of implants who had ovarian cysts than in those with no ovarian enlargement. Conclusions: The finding of ovarian cysts or enlarged ovarian follicles during the first year of use of Implanon (R) and Jadelle (R) implants is common and transient and should not be interpreted as a pathologic ovarian cyst. No further medical interventions are necessary. (c) 2006 Elsevier Inc. All rights
dc.publisher.cityNew Yorkpt_BR
dc.publisherElsevier Science Incpt_BR
dc.identifier.citationContraception. Elsevier Science Inc, v. 73, n. 5, n. 532, n. 536, 2006.pt_BR
dc.sourceWeb of Sciencept_BR
dc.description.provenanceMade available in DSpace on 2014-11-14T04:02:37Z (GMT). No. of bitstreams: 1 WOS000237208500015.pdf: 128242 bytes, checksum: 7b1166961ee4a8a99f8c46761a47bc16 (MD5) Previous issue date: 2006en
dc.description.provenanceMade available in DSpace on 2015-11-26T17:13:02Z (GMT). No. of bitstreams: 2 WOS000237208500015.pdf: 128242 bytes, checksum: 7b1166961ee4a8a99f8c46761a47bc16 (MD5) WOS000237208500015.pdf.txt: 25541 bytes, checksum: 40001e923bdf211704d65b10162bd0b6 (MD5) Previous issue date: 2006en
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000237208500015.pdf125.24 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.